Insulin aspart, human

NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear.

Drug facts

Used for: NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.

What it is used for

NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Insulin aspart, human; [reviewed 2026 Aug 3; cited 2026 Nov 11]. Available from: https://sofidex.com/patients/medicines/insulin-aspart-human
APA 7th: sofidex. (2026, August 3). Insulin aspart, human. Daloreum. Retrieved November 11, 2026, from https://sofidex.com/patients/medicines/insulin-aspart-human
AMA 11th: Insulin aspart, human. sofidex. Reviewed August 3, 2026. Accessed November 11, 2026. https://sofidex.com/patients/medicines/insulin-aspart-human

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.